By SmashMeals Editorial — 2026-09-14 — Health & Nutrition
KINGSPORT, Tenn., Sept. 14, 2026 — 2026 is the year the GLP-1 pill arrived. Novo Nordisk's oral semaglutide tablet launched early in the year, and Eli Lilly's oral tirzepatide pill began shipping in April. Reporting on both notes they're priced close to the injectable versions — and that trial data has shown them somewhat less effective for weight loss than the shots.
Educational only — not medical advice. SmashMeals is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.
A new route, not a new mechanism
A pill and an injection of the same molecule work on the same appetite and digestion pathways — reduced hunger, slower gastric emptying, and for many people, the same reported side effects: nausea, early fullness, and less interest in food generally. Whether someone takes a shot or a tablet, the practical eating question is identical: how do you get enough protein into a much smaller amount of food?
Why the eating strategy doesn't change
Nothing about switching delivery method changes what clinicians have been recommending since GLP-1s first launched for weight loss: protein-first plates, smaller and more frequent meals, and avoiding the fried, heavy, or sugary foods that tend to be hardest to tolerate on a suppressed appetite. "The form changes — pill or pen — but the plate doesn't," said Lew Kizer, founder of SmashMeals. "You've still got a smaller window to get real nutrition in."
Where SmashMeals fits
Every SmashMeals entrée is chef-prepared with protein that varies by meal and full macros posted on the label, cooked in a 100% dedicated gluten-free kitchen in Kingsport, TN since 2017. Meals ship $30 flat-rate FedEx Ground to eligible addresses, with no subscription required — an option for anyone adjusting to a smaller appetite, on a pill, a pen, or neither.
Sources & experts referenced
Sources are included for verification. No expert listed here endorses SmashMeals.